A novel diagnostic technology for urinary tract infection. Infectious diseases remain one of the greatest challenges to global health. Urinary tract infection (UTI) is considered to be the most common bacterial infection and poses a significant healthcare burden. Almost 50% of the global population will suffer from a UTI at some point in their lives. Financially, the estimated global annual cost of UTI is significant, at approximately $5 billion. A key barrier towards improving the management of UTI is the absence of rapid and accurate diagnostic information to direct treatment decisions. The current technologies employed for UTI diagnostics are slow, expensive and prone to human errors. The outlined technology is a simple, rapid, inexpensive, semi-automated and accurate UTI diagnostic test.
The technology employs real-time monitoring and computational analysis of non-isolative liquid urine cultures using existing off-the-shelf technology. It allows for rapid determination of Colony Forming Unit (CFU) value without the need to perform manual colony counting.